help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliveira, C. A.
Right arrow Articles by Hess, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliveira, C. A.
Right arrow Articles by Hess, R. A.
Endocrinology Vol. 143, No. 6 2399-2409
Copyright © 2002 by The Endocrine Society


REPRODUCTION-DEVELOPMENT

ER Function in the Adult Male Rat: Short- and Long-Term Effects of the Antiestrogen ICI 182,780 on the Testis and Efferent Ductules, without Changes in Testosterone

Cleida A. Oliveira, Qing Zhou, Kay Carnes, Rong Nie, David E. Kuehl, Gary L. Jackson, Luiz R. Franca, Masaaki Nakai and Rex A. Hess

Department of Veterinary Biosciences (C.A.O., Q.Z., K.C., R.N., D.E.K., G.L.J., M.N., R.A.H.), University of Illinois, Urbana, Illinois 61802; and Departments of Morphology and Physiology (C.A.O., L.R.F.), Federal University of Minas Gerais, Belo Horizonte-MG, Brazil 31270-901

Address all correspondence and requests for reprints to: Dr. Rex A. Hess, Veterinary Biosciences, University of Illinois, 2001 South Lincoln, Urbana, Illinois 61802-6199. E-mail: . r-hess{at}uiuc.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Male rats, 30 d old, were treated with the antiestrogen ICI 182,780 (3–150 d) to determine sequences of events leading to testicular atrophy and infertility. Plasma testosterone and LH concentrations were unchanged. ICI 182,780 induced dilation of efferent ductules as early as 3 d post treatment, and the dilation increased over time, resulting in an overall increase of 200% in tubule diameter. A gradual reduction in height of the ductule epithelium was observed; however, the microvilli height increased up to d 73 but subsequently decreased. A transient increase in lysosomes in nonciliated cells was seen from d 15 to d 100. Testicular weight increased by d 45 and seminiferous tubules were dilated by d 52. These effects on testes persisted until d 100, but on d 150 the weight decreased and severe atrophy was observed. These testicular effects were probably owing to accumulation of fluid following inhibition of reabsorption in the efferent ductules, similar to the ER-{alpha} knockout mouse. In agreement with this conclusion, there was a decrease in Na+-H+ exchanger-3 mRNA and protein, which is consistent with previous studies showing that ER is required for expression of Na+-H+ exchanger-3 and ultimately fluid reabsorption in the efferent ductules.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
TARGETED DISRUPTION OF mouse ER-{alpha} ({alpha}ERKO) or both ER{alpha} and ERß ({alpha}ßERKO) has demonstrated that ER{alpha} is essential for fertility in the male and that estrogen has a role in the regulation of the male reproductive tract (1, 2, 3, 4, 5). In the {alpha}ERKO and antiestrogen-treated mice, efferent ductules, which are small tubules that transport sperm from the rete testis to the epididymis, showed the most severe histopathological changes following ER disruption (1, 6, 7, 8). This is not surprising because this region of the male reproductive system expresses the highest concentration of ER-{alpha}, which is even higher than that found in normal female tissues (9, 10, 11, 12, 13, 14). The lumen of efferent ductules in {alpha}ERKO and antiestrogen-treated mice were dilated and the epithelium was regressed. There was clear evidence that disruption of ER{alpha} in the male mice results in the inhibition of fluid reabsorption in efferent ductules (1, 6, 7, 8).

Efferent ductules are responsible for the reabsorption of more than 90% of the fluid leaving the testis (15). This important physiological function is similar to that in the proximal tubules of the kidney, involving the active transport of Na+ from the lumen toward the basement membrane and passive movement of water toward the ion concentration gradient (16). This mechanism includes the participation of a Na+,K+-ATPase along the basolateral membrane (17), the Na+-H+ exchanger-3 (NHE3) and aquaporin-1 on the microvillus border (18, 19, 20, 21, 22) and carbonic anhydrase (CAII) in the apical cytoplasm (23, 24). In a recent study, NHE3 was shown to be the major protein regulated by estrogen to mediate fluid reabsorption in the efferent ductules (25). Effects of ER{alpha} disruption on aquaporin-1 and CAII appeared to be secondary because their mRNAs were not decreased, but that of NHE3 was reduced by 60–80% in {alpha}ERKO and ICI 182,780-treated mice.

Although ICI 182,780 treatment in the adult mouse results in male reproductive tract effects similar to the {alpha}ERKO mouse (7), the {alpha}ERKO male does contain developmental defects that persist in the adult tissues (8). Furthermore, differences between species in the distribution of ER{alpha} and ERß in the male reproductive tract have been reported (8, 10, 11, 26), and sensitivity to estrogens and antiestrogens has been found to differ among species and animal strains (27, 28, 29, 30, 31, 32). Therefore, further development of the ICI-treatment model in the adult male remains an important goal and the rat was selected as an alternative species (33). The antiestrogen ICI 182,780, which is a steroidal antiestrogen that binds to both ER{alpha} and ERß (34, 35) and does not cross the blood-brain barrier (36), was used for an extended period of treatment (100 and 150 d) in the rat model. This long-term treatment reproduced the male reproductive tract phenotype seen in {alpha}ERKO, including testicular atrophy and infertility (33). The success of ICI 182,780 treatment in adult male rats substantiated the role of estrogen in the male tract without the problems associated with developmental absence of ER, which is found in the knockout mice. However, it was still unclear whether the changes in testis and efferent ductules resulted from primary or secondary effects of treatment. These results prompted us to evaluate the time-response effects of ICI 182,780 to determine the sequence of events leading to infertility and testicular atrophy and to test the hypothesis that estrogen regulates the NHE3 in efferent ductules of rat. The focus of this study was on testicular and efferent ductule effects because prior studies have shown these regions to be major sites of pathological change following the disruption of ER in the male.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Outbred, 30-d-old (major experiment) and 90-d-old, male Sprague Dawley rats (Harlan Bioproducts, Indianapolis, IN) were used in the experiment. The rats were housed at a constant light cycle (12 h of light, 12 h of darkness) and temperature (22 C). They received commercial diet (Teklad Chow, Harlan Teklad, Madison, WI) and tap water ad libitum. All animal experiments were approved by the University of Illinois Division of Animal Resources and conducted in accordance with the Guide for the Care and Use of Laboratory Animals (37).

Treatment
Beginning at 30 d of age, the rats were treated once a week with sc injections of a long-acting formulation of ICI 182,780 (Faslodex, kindly provided by AstraZeneca, Macclesfield, UK), at a dosage of 10 mg/animal in a volume of 0.2 ml vehicle. This dosage was found to be effective for inducing effects on rat efferent ductule without inducing significant differences on body and sexual gland weights (33). The control group received the same volume of castor oil. Matched control and ICI-treated rats (three animals per group) were euthanized on d 3, 15, 45, 52, 73, 100, and 150 after the first injection for the histological study; on d 7, 15, 45, and 100 for immunohistochemistry (three animals per group); on d 45 for acid phosphatase detection (two animals per group); and on d 3 and 55 for Northern blot analysis (25 animals per group, with pooled tissues in each group). Because rats are still growing at 30 d of age and some developmental effects of ICI 182,780 could occur, we treated a separate group of four mature adult male rats (90 d old) for comparison of the effects of ICI 182,780 treatment beginning at full maturity (treated for 45 d) with those at 30 d old.

Histology
The rats were anesthetized (ip sodium pentobarbital 0.1 ml/100 g body weight), weighed, and perfused intracardially with 4% (wt/vol) glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4. The testes, reproductive tract, ventral prostate, and seminal vesicles (with coagulating glands) were removed, immersed in the same fixative, and stored at 4 C for further processing. After fixation, the testes were dissected from the efferent ductules, weighed, and cross-sectioned at the midrete testis. Weights of the accessory sex glands were also recorded after fixation. The efferent ductules as well as the testis sections were embedded in glycol methacrylate resin, sectioned at 2.5 µm, and stained with 1% toluidine blue or periodic acid-Schiff (PAS) with hematoxylin counterstain.

Morphometry
Histological sections were analyzed morphometrically using NIH image software (http://rsb.info.nih.gov/nih-image). Images were obtained using a Spot-2 digital camera (Diagnostic Instruments Inc., Sterling Heights, MI) and plan apochromatic lenses (Olympus Corp. America Inc., Melville, NY) and processed using a MAC-G3 computer (Apple Computer, Cupertino, CA) with Adobe Photoshop (San Jose, CA).

The seminiferous tubule diameter and luminal area were measured in 10 randomly selected round cross-sections of tubules, at stages VII-VIII, except for testis on d 3 and 150. On d 3, spermatogenesis was still incomplete and the lumen was not patent in some seminiferous tubules. On d 150 most of the seminiferous tubules were atrophic.

The efferent ductule luminal diameter was determined by measuring the widest diameter of five sections of tubules from the proximal area. The proximal area was selected because past studies had shown a similar reaction in proximal and distal regions (our unpublished data), and the proximal region is responsible for reabsorption of approximately 70% of the fluid entering the efferent ductules (15). The epithelial height was measured in straight sections of the epithelium, in 25 cells/animal. Height of the microvillus border was measured in the same cells.

To estimate percent area of PAS-positive lysosome-like granules in nonciliated cells, images (Adobe Photoshop) were changed to CMYK and then adjusted using the channel mixer command (monochrome, cyan -200%, magenta +200%). The pictures were then opened with NIH image software, and an epithelial area composed of five consecutive nonciliated cells was outlined and measured. To discriminate the lysosomes from surrounding background, the density-slicing mode was used. Then the area occupied by the highlighted lysosomes was measured. The amount of lysosomal granules per 100 µm2 was calculated.

Immunohistochemistry
NHE3 was localized by immunohistochemistry in efferent ductules of treated and control animals on d 7, 15, 45, and 100. Tissue sections from treated and control animals at each time point were run in parallel, and all staining was replicated to confirm the results. Tissues were fixed by perfusion with neutral buffer formalin, embedded in paraffin, and stained using standard methods for microwave antigen retrieval. Sections were incubated for 12 h at 4 C with diluted (1:500) primary antibody, a polyclonal rabbit antirat NHE3 (Chemicon International, Temecula, CA). For negative controls, the sections received PBS in place of the primary antibody. Renal tissue was used for positive control. After washing in PBS, sections were incubated with a secondary antibody, biotinylated goat antirabbit IgG, diluted 1:100 (DAKO Corp., Glostrup, Denmark) for 1 h at room temperature, and then incubated with the avidin-biotin complex (Vector Laboratories, Inc., Burlingame, CA) for 30 min. Reactivity was visualized using DAB chromogen. Sections were counterstained with Mayer’s hematoxylin.

Northern blot analysis
Tissues for total RNA analysis on d 3 and d 55 after the first injection were collected and pooled from 25 control and 25 treated rats, respectively. Total RNA was isolated from efferent ductules by the guanidinium isothiocyanate/phenol chloroform method. After electrophoresis of total RNA (20 µg) on a 1.5% formaldehyde denaturing agarose gel and blotting to Duralon-UV membranes (Stratagene, La Jolla, CA), the membrane was prehybridized in QuikHyb solution (Stratagene) for 2 h and then hybridized with denatured 32P-labeled probes and sonicated salmon sperm DNA at 58 C overnight. After hybridization, the filters were washed twice for 5 min each at room temperature in 2x sodium citrate-buffered saline-0.1% SDS, followed by a 10-min wash in 0.1x sodium citrate-buffered saline-0.1% SDS at 65 C. The NHE3 probe was a PCR product from rat NHE3 cDNA plasmid. Primers for NHE3 were 5'-TGGATTTCCTGCTATTTGGC-3' and 5'-TCGCTCCTCTTCACCTTCA-3' (GenBank accession no. M85300, nt615-1485). The Northern blots were normalized for variations in loading by a final hybridization with the 36B4 probe, which is not influenced by estrogen treatment (38). Relative quantification was made by digitizing images using UN-SCAN-IT (Silk Scientific, Orem, UT).

Hormone measurement
Plasma levels of testosterone and LH were estimated by RIA. Blood samples were obtained by cardiac puncture immediately before death. The plasma was separated by centrifugation and stored at -20 C for subsequent hormone assays. All samples were measured in duplicate.

Plasma concentration of LH was estimated by a double antibody method, using rat LH-RIA immunoreagents (antirat LH-S-11 antisera, rat LH-I-9 IOD, and rat LH-RP-3) and procedures provided by the National Hormone and Pituitary Program (NIDDK, Rockville, MD). The NIDDK rat LH-RP-3 preparations were used as standards. The assay sensitivity was 0.2 ng/ml and the intraassay coefficient of variation was 8%.

Plasma testosterone level was measured using an antibody to 4- androsten-11{alpha}, 17ß-diol-3-one-11-hemisuccinate. BSA (antitestosterone 1969–11B) developed by Dr. O. D. Sherwood (University of Illinois, Urbana, IL) (39). Cross-reactivity with E2 and estrone was less than 0.0001 (0.01%) each. The only significant cross-reactivity of the antisera was with 5{alpha}-androstan-17ß-ol-3-one (5{alpha}-DHT) (52%). However, because of the low circulating levels of 5{alpha}-DHT in the male rat (40, 41), the interference of DHT is considered to be negligible (42); therefore, the results were expressed as nanograms of testosterone. For the assay, plasma was extracted with toluene:petroleum ether (2:5 vol/vol). The efficiency of the extraction was 86.5%. The limit of detection was 0.2 ng/ml and the intra- and interassay coefficients of variation averaged 6.6% and 2.8%, respectively. The reported plasma concentrations of testosterone were corrected for recovery.

Acid phosphatase activity
For identification of lysosomes, the Gomori histochemical method for acid phosphatase was used (43). Efferent ductules from d 45 ICI-treated and control rats were fixed by perfusion with neutral buffer formalin, frozen in liquid nitrogen and stored at -20 C. Liver tissue was used as positive control. Frozen sections (8 µm) were incubated for 20 min at room temperature in the medium with Na-ß-glycerophosphate (Sigma, St. Louis, MO) as a substrate. Following incubation, the sections were washed in distilled water and transferred to 1% ammonium sulfide solution to develop the stain. The reaction was monitored microscopically and was stopped by immersion in distilled water when a dark brown positive reaction was observed. As negative control, slides were incubated in the medium without the Na-ß-glycerophosphate substrate. To assure that the observed reaction was specific, an inhibition test was performed by adding to the incubation medium sodium fluoride (10 mM), which is a specific inhibitor of the acid phosphatase activity.

Statistics
Data were analyzed by two-way ANOVA to compare the differences between treated and control groups. Multiple post hoc comparisons was performed by a Newman-Keuls test to detect differences at individual time points (P < 0.05). Results are presented as mean ± SEM.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The effects induced by ICI 182,780 treatment were first detected in efferent ductules on d 3 post treatment. Effects in the testis were delayed; therefore, the results are presented in this sequence. Throughout the study, peripheral blood concentrations of LH and testosterone were not significantly different between control and the ICI-treated animals (Table 1Go). There were no treatment differences in body weight (Table 1Go). Weight of the ventral prostate and seminal vesicle-coagulating glands also showed no difference between controls and ICI-treated males (Table 1Go), neither in absolute weights of the glands nor weight relative to body weight.


View this table:
[in this window]
[in a new window]
 
Table 1. Effects of ICI 182,780 on plasma LH and T concentration, body, ventral prostate, and combined seminal vesicles/coagulating glands weights1

 
Efferent ductules
The proximal efferent ductules showed luminal dilation after ICI 182,780 treatment at all time points analyzed (Figs. 1AGo and 2Go). The overall increase in luminal diameter of the efferent ductules proximal region was 199.4%. Luminal dilation was first observed at d 3 post treatment in some ductules. Thereafter the ductules had statistically significant and progressive dilation, showing maximum dilation on d 73 and remaining dilated until d 150. Coincident with the efferent ductule dilation, a significant decrease in the epithelial height occurred following the ICI 182,780 treatment (Fig. 1BGo). Starting from d 15, epithelial height was significantly less than controls. A gradual decrease in epithelial height over time was observed in the ICI-treated ductules, with the mean value reaching a plateau on d 52. Although a similar mean height was found in treated animals from d 52 to d 150, there was a large variation in height in some epithelial areas, even in the same tissue section (Fig. 3Go). Compared with the controls, the maximum decrease in height (48% decrease) was found on d 150, when a large proportion of cuboidal cells were observed (Fig. 3Go). Conversely, a gradual increase in epithelial height was observed over time in control efferent ductules (Fig. 1BGo).



View larger version (39K):
[in this window]
[in a new window]
 
Figure 1. Effects of ICI 182,780 on rat proximal efferent ductules. A, Luminal diameter of the efferent ductules was increased significantly (*, P <= 0.05) at all time points post treatment. The maximum dilation occurred after 73 d of treatment. B, The height of the efferent ductules epithelium decreased after treatment, reaching a plateau on d 52. Conversely, the epithelium in control efferent ductules increased over time. C, Microvillus border of efferent ductule epithelia was taller in ICI-treated rats up to d 73; however, on d 100 and 150 a significant (*, P <= 0.05) decrease in the height of microvilli was observed. Lower microvillus border on d 52 was found in treated and control rats, indicating a potential fixation problem. D, A significant (*, P <= 0.05) increase in lysosomal area per 100 µm2 of nonciliated cells cytoplasm was seen up to d 100; however, on d 150 a significant (*, P <= 0.05) decrease in the lysosomal area occurred, reaching levels even lower than in control animals. Values represent mean ± SEM (n = 3 in each group). No error bar is seen where the errors are too small to draw.

 


View larger version (91K):
[in this window]
[in a new window]
 
Figure 2. Changes in luminal diameter of rat efferent ductules after ICI 182,780 treatment. Compared with control rats (A), which present a thin luminal diameter, the efferent ductules lumen was already dilated on d 3 in ICI-treated rats (B). The efferent ductules lumen was narrow in all control rats (A, C, E, G), but a gradual increase in the luminal diameter was observed overtime (B, D, F, H) in treated rats. Maximum dilation was reached on d 73 (H) and continued similar thereafter. A reduction in efferent ductules epithelial height was evident on d 45 (compare E and F) and d 73 (compare G and H). Bar in A, 100 µm.

 


View larger version (108K):
[in this window]
[in a new window]
 
Figure 3. Morphology of the rat efferent ductules epithelium on d 3, 45, 52, 73, 100, and 150 after ICI 182,780 treatment. Mv, Microvilli; Ly, lysosomes; L, lipid droplets; c, ciliated cells. Control tissues (A, E, I, L, P, T) at different time points showed tall nonciliated and ciliated epithelia with prominent microvillus borders. Lysosomes were confined to the supranuclear cytoplasm, and lipid droplets were seen in the basal cytoplasm. The epithelium on d 3 of treatment was similar to control in terms of epithelium and microvillus border height. The lysosomes have already changed to a perinuclear position in some cells (B, C), but they were still supranuclear in other areas (D). On d 45 post treatment, the epithelium was still tall in some areas (F) but decreased in others (G, H), but the microvillus borders were still normal in appearance. The lysosomes were increased in number and had a perinuclear location. On d 52 post treatment, the epithelium was shorter, but the microvillus border was similar to control. Lysosomes were abundant and redistributed around the nucleus. After 73 d of treatment, the epithelium height was much shorter than control, with some areas already cuboidal in appearance (O). The microvillus border varied from normal in appearance to very short (O). Numerous lysosomes were present around the nucleus in some cells (M, N); however, other areas contained few lysosomes (O). On d 100 post treatment, the epithelial height was reduced but still columnar, and the microvillus border appeared normal in some cells (Q, R), but in other areas (S) the epithelium and microvilli were short. Variable amounts of lysosomes were seen at this time point. On d 150 post treatment, the efferent ductules epithelium was short, with cuboidal cells being more common than columnar (V). Height of the microvillus border and the number of lysosomes were reduced. (Bar in A, 10 µm).

 
The height of the microvillus border showed a large variation in both treated and control animals (Fig. 1CGo). However, there was a clear trend for increased microvillus border height from the beginning of the ICI 182,780 treatment until d 73, whereas thereafter a decrease in microvillus border height was detected, culminating with a 39% decrease at d 150. The only exception was seen on d 52, when a lower microvillus border was found for both treated and control animals, suggesting a potential problem with tissue fixation. Coexistence of areas with variable microvillus border height was frequently seen in the treated efferent ductule epithelium from d 73 to d 150 (Fig. 3Go).

Beginning on d 15 post treatment and continuing until d 100, there was a significant increase in the percent area occupied by PAS-positive granules in 100 µm2 of the nonciliated cell cytoplasm, compared with controls (Figs. 1DGo and 3Go). The granules were identified as part of the lysosomal compartment, based on their acid phosphatase activity. The maximum effect on lysosomes occurred on d 52 when there was a 172% increase in lysosomal area per 100 µm2 area of cytoplasm. After d 73, the lysosomal area in ICI-treated tissues decreased, and on d 150 was lower than controls (64% decrease). In the treated group, lysosomes were redistributed within the cytoplasm (Fig. 3Go). They were surrounding the nucleus and occupying the basal cytoplasm, whereas in control nonciliated cells, lysosomes were fewer than treated group and seen in the supranuclear and apical cytoplasm. The distal efferent ductules contained fewer lysosomes in both control and treated animals. Early endocytotic components of the lysosomal system, which were identified by toluidine-blue and PAS staining as clear vesicles in the adluminal cytoplasm, were evident in control animals as well as in ICI-treated cells. However, these vesicles appeared decreased in some cells after d 73 of treatment and almost disappeared at d 150.

Rete testis
At all time periods after d 3, the rete testis lumen was dilated following ICI 182,780 treatment, compared with controls (Fig. 4Go). At d 3 the rete testis was dilated in only one of three animals. Rete testis dilation increased over time with ICI 182,780 treatment. The rete testis epithelium did not show consistent changes in cell height or morphology after treatment.



View larger version (129K):
[in this window]
[in a new window]
 
Figure 4. Morphology of the rat rete testis (outlined with black) after ICI 182,780 treatment. On d 3 post treatment, the rete testis was thin in control rats (A) as well as in two treated animals (B) but dilated in another (C). On d 45, dilation of the rete testis was observed when controls (D) and treated (E) rats were compared. On d 73, the rete testis was thin in control animals (F) but markedly dilated in treated rats (G). At the end of the treatment on d 150, the rete testis remained dilated in treated rats (I), compared with controls (H). Bar in A, 500 µm.

 
Testis
Testis weights increased in parallel from d 3 to d 15 in both controls and treated animals (Fig. 5Go). However, on d 45, the weight of testes in ICI-treated males increased rapidly over controls and continued heavier until d 100. The increase in testis weight on d 45 of ICI 182,780 treatment was accompanied by dilation of the seminiferous tubule lumen, which was evident from d 52 to d 100, independent of the cycle stage of the seminiferous epithelium (Figs. 5Go and 6Go). After d 100, a sharp decrease in testis weight was seen, compared with controls. No remarkable histological difference was noted in the seminiferous epithelium between controls and ICI-treated rats, until d 150 when most tubules were atrophic in the treated rats (Fig. 6Go).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 5. Effects of ICI 182,780 on rat testes. A, The paired testes weights of control and ICI rats increased in parallel until d 15, after which an increase in weight of ICI testes over controls was evident from d 45 to d 100. On d 150 a significant decrease in weight was observed in treated rats, compared with controls. B, On d 52–100 post treatment, the seminiferous tubule luminal area was increased significantly. Values represent mean ± SEM (n = 3 in each group). *, P <= 0.05. No error bar is seen where the errors are too small to draw.

 


View larger version (149K):
[in this window]
[in a new window]
 
Figure 6. Morphology of the rat testis after ICI 182,780 treatment. On d 45 the seminiferous tubule lumen was thin in control rats (A) as well as in treated (B). On d 52 the seminiferous tubule lumen was thin in control rats (C), but luminal dilation was evident in treated (D). On d 100, the lumen of seminiferous tubule was thin in control rats (E) but dilated on treated (F). On d 150, the seminiferous epithelium was normal in appearance in controls (G), but tubular atrophy was evident after treatment (H). Bar in A, 100 µm.

 
NHE3
The expression of NHE3 in the rat efferent ductules was detected on the brush border of nonciliated cells but not in ciliated cells (Fig. 7Go). There was a gradient of NHE3 staining, increasing from proximal to distal regions of the ductules. Immunoexpression of NHE3 was decreased slightly on d 7 in nonciliated cells of the treated efferent ductules. The staining intensity continued to decrease over time until staining was barely detectable on d 100 of ICI 182,780 treatment (Fig. 7Go). In agreement with the immunohistochemical results, NHE3 mRNA was reduced 98.5% in ICI-treated animals, compared with controls on d 55 post treatment (Fig. 8Go) but on d 3 the message was not reduced (data not shown).



View larger version (109K):
[in this window]
[in a new window]
 
Figure 7. Expression of NHE3 on rat efferent ductules after ICI 182,780 treatment; c, ciliated cells. A, In the control rat, NHE3 was expressed along the apical microvillus border of the efferent ductule nonciliated cells. Ciliated cells were not stained. B, On d 7 of ICI 182,780 treatment, a moderate decrease in NHE3 expression was noted along the apical microvillus border of the efferent ductule nonciliated cells. C, Control rat on d 45 showed strong staining for NHE3 in the nonciliated cells. D, After 45 d of ICI 182,780 treatment, NHE3 staining was further decreased in nonciliated cells. E, Control rat on d 100 shows intense staining for NHE3 in the nonciliated cells. F, On d 100, NHE3 staining was decreased to barely detectable levels in nonciliated cells. Bar in A, 50 µm.

 


View larger version (52K):
[in this window]
[in a new window]
 
Figure 8. Effects of ICI 182,780 treatment on mRNA expression in efferent ductules. NHE3 mRNA was decreased 98.5% on d 55 following ICI 182,780 treatment, compared with control (Con). The Northern blot was normalized for loading by a final hybridization with the 36B4 probe, a cDNA for human acidic ribosomal phosphoprotein, which is nonresponsive to estrogen (60 ).

 
Mature adult treatment
Treatment with ICI 182,780 for 45 d starting at 90 d of age (full adult) caused changes in the rat testis and efferent ductules similar to those observed over the same time period (45 d) but starting treatment at 30 d old (prepubertal). The adult rats also showed increase in testis weight, dilation of the rete testis, and efferent ductules as well as increase in number and redistribution of lysosomes in nonciliated cells.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The antiestrogen ICI 182,780 induced gradual effect on the male rat reproductive system, with some effects observed as early as 3 d after the first treatment, with other effects being delayed. The sequence of events included: 1) luminal dilation of the efferent ductules and rete testis from d 15 to d 150; 2) decreased efferent ductule epithelial height from d 45 to d 150; 3) a transient increase in lysosomal granules and microvillus border height from d 15 to d 73; 4) an increase in testicular weight from d 45 to 100; 5) an increase in seminiferous tubule diameter and luminal area from d 52 to d 100; 6) a decrease in lysosomal granule area and microvillus border height after 100 d; and 7) testicular atrophy on d 150. Many of these effects were also found in the adult {alpha}ERKO mouse (7, 8); however, the developmental sequence of changes in the {alpha}ERKO male tract has not been reported.

Long-term effects of ICI 182,780 resembled an {alpha}ERKO-like reproductive tract phenotype and culminated in testicular atrophy and infertility in the rat (33). Here we describe for the first time the sequence of changes in the efferent ductules and testis that preceded the terminal events of testicular atrophy. Additionally, it is shown that the mechanism by which estrogen regulates fluid reabsorption is related to the expression of NHE3 in nonciliated cells of the efferent ductules. It is noteworthy that all changes seen in efferent ductules after antiestrogen treatment occurred without effects on the concentration of plasma testosterone. This observation reinforces the importance of estrogen in the male reproductive tract, especially within this unique region whose function appears to be essential for fertility.

Testosterone and LH concentrations in blood plasma were not changed following ICI 182,780 treatment. Body and accessory sex gland weights were also unaffected at all time points, demonstrating that ICI 182,780 had a specific peripheral action in the male rat reproductive tract. Plasma E2 concentrations were not determined because of difficulties in separating ICI 182,780 from endogenous blood estrogens. However, because the parameters above are susceptible to serum levels of E2 (44) and they were similar to controls, it is unlikely that E2 levels were altered. In contrast to ICI-treated rats, serum LH (45) and testosterone levels were increased in {alpha}ERKO mice (3, 45). Aromatization of testosterone to E2 and a functional ER{alpha} has been shown to be essential in the negative feedback action of androgens in the male hypothalamus-pituitary axis (26, 45, 46, 47, 48). Therefore, the difference in hormone levels between the {alpha}ERKO mouse and ICI-rat can be explained at least in part because ER{alpha}- mediated action is absent in the {alpha}ERKO brain but not in the ICI-treated rat because ICI 182,780 does not cross the brain barrier (36).

There was an unprecedented increase of 200% in luminal diameter in the efferent ductules after ICI 182,780 treatment. Luminal dilation represented one of the first effects of ICI 182,780 treatment as seen on d 3. In {alpha}ERKO mice, dilation of efferent ductules was also a primary effect of ER disruption (7, 8); however, dilation of the efferent ductules was greater in ICI-treated mice of the same age (7). Surprisingly, aromatase knockout mice (49) and aromatase inhibitor-treated rats (50) did not show such response, indicating that a functional ER{alpha} is required for maintenance of efferent ductule fluid physiology. The apparent added increase in luminal diameter following antiestrogen treatment is probably owing to effects of ICI 182,780 on Cl- secretion because the ligated {alpha}ERKO ductule in vitro showed 40% increase in diameter (1). Recent studies have also shown an increase in mRNA for the chloride channel, cystic fibrosis transmembrane regulator (CFTR), in {alpha}ERKO and ICI-treated male rat efferent ductules (51).

Conversely to the dilation of efferent ductules, the rete testis dilation was greater in the {alpha}ERKO mouse than after ICI 182,780 treatment in mouse or rat (7, 33). This difference is most likely owing to developmental abnormalities in the {alpha}ERKO (7). In the rat, the rete testis was not dilated in two of three animals on d 3, which is indicative that the dilation of efferent ductules preceded the dilation of the rete testis. In addition, the efferent ductule dilation was present before seminiferous tubule dilation and persisted until the end of the experiment, when the testes became atrophic. These results are consistent with the hypothesis that dilation of the efferent ductules occurs because of a decrease in efferent ductule fluid reabsorption, which leads ultimately to the accumulation of fluid in the testis (1, 52).

In the present study, a transient increase in testicular weight occurred from d 45 to d 100. This response was similar to that described for the {alpha}ERKO mouse from d 32–45 to d 90–100 (1). In the rat, the increase in testis weight correlated in time with dilation of seminiferous tubules from d 52 to d 100. It was during this time period that the efferent ductules reached their maximum dilation. Therefore, it is reasonable to postulate that the maximum accommodation of fluid in the efferent ductules was achieved before the buildup of fluid within the testis, which would induce subsequent swelling of the testis, followed by atrophy of the seminiferous epithelium (1, 33, 52). Similar to the effects seen in the testes of ICI-treated rats, which took 150 d to become atrophic (this study and 33), testicular disruption required an extended period of time to be manifested in the {alpha}ERKO and {alpha}ßERKO males (3, 5). Disruption of spermatogenesis was also delayed in the aromatase knockout males (49).

The efferent ductules displayed severe morphological effects in the {alpha}ERKO and ICI-treated mice (1, 7, 8). However, in the ICI-treated rat, the epithelial cells showed less reduction in height than was seen in the mice and the height stabilized after 52 d of treatment, which coincided with the time period during which the efferent ductule lumen reached its maximum dilation. The {alpha}ERKO-like effect on the epithelium was not observed in the rat until the end of the experiment on d 150. However, the degree of luminal dilation does not appear to cause the epithelial disruption because it was recently shown that the efferent ductule lumen was dilated even to a greater extent in the NHE3 knockout mouse, but its ductal epithelium was columnar and normal in every respect (25). Therefore, a difference between these two rodent species in response to antiestrogen treatment is evident.

The microvillus border of nonciliated cells of the efferent ductules was decreased in height or often missing in {alpha}ERKO and ICI-treated mice (1, 6, 7, 8). However, in the present study, the microvillus border showed large variations in height, with an increase in the height up to d 73 but an overall decrease thereafter. A taller microvillus border is suggestive that the epithelium is attempting to compensate for the inhibition of fluid reabsorption. Such a response would be similar to the NHE3 knockout mouse and CAII-deficient mice, which had efferent ductule with greater dilation and taller epithelium than {alpha}ERKO (25). We have no explanation for the differences between mice and rats in response to ICI 182,780, but it is clearly evident that disruption of ion and water transport, which accounts for the fluid accumulation in the efferent ductules (25), is independent of the effects on epithelial morphology.

Evidence that an Na+/H+ exchanger is the principal physiological mechanism responsible for fluid and electrolyte reabsorption in the rat efferent ductules has already been shown by microperfusion in vivo (19). In that study, approximately 70% of fluid reabsorption was dependent on this exchanger. Confirming the physiology, an active NHE3 protein was detected in the apical membrane of rat efferent ductules nonciliated cells (20, 21). In the ICI-treated rat efferent ductules, NHE3 protein was beginning to show decreased expression by d 7 and the reduction became greater over time, reaching levels nearly undetectable by d 100. This decrease was consistent with Northern blot analysis showing a decrease of 98.5% in the NHE3 mRNA on d 55. Although we did not determine the exact date for effects on NHE3 mRNA, it is likely between d 3 and d 7 when the protein began to decline. As in the mouse, in which NHE3 expression and Na+ transport have been shown to be regulated by estrogen (25), loss of this important ion exchanger was independent of apical cytoplasmic disruption. It is unlikely that the decrease of NHE3 protein (as early as d 7 after treatment) and mRNA (55 d post treatment) is owing to the loss of the apical microvillus brush border because microvillus height is greater than controls up to d 73.

Although the increase in luminal diameter was not significant on d 3, it is interesting that some lumens began dilating so rapidly before an overall change in NHE3 expression. Possible explanations include an increase in secretion by testis or the efferent ductule epithelium. However, on d 3 the animals were only 33 d old and the testicular secretions had not reached normal levels, as evidenced by the lack of opening of the seminiferous tubule lumens in many tubules. Thus, the efferent ductules were not at this time under normal estrogen and androgen stimulation from the lumen. Also, our previous study showed that in the {alpha}ERKO male, there was no increased testicular secretion, but rather a decrease was observed (1). The same study also found that in vitro ligated efferent ductule segments increased in luminal area, suggesting that in addition to regulating fluid reabsorption, estrogen in the male tract also regulated secretion, possibly of Cl- through CFTR, which is expressed in the efferent ductule epithelium (53). Another explanation is found in the potential for ICI 182,780 to inhibit both ER{alpha} and ERß in this tissue (54). A recent study found that ICI treatment of mice increases CFTR mRNA (51). Treatment of both the rat and the mouse with ICI 182,780 resulted in proportionally greater dilation of the efferent ductule lumen than in the {alpha}ERKO mouse (1, 7, 33). Therefore, it is reasonable to propose that this pure antiestrogen is inhibiting NHE3 as well as other factors responsible for ion and fluid reabsorption. Thus, the first response to ICI 182,780 may be increased Cl- secretion, which would cause slight dilation of the ductule lumen, followed by decreased expression of NHE3 with subsequent loss of Na+ and water transport, ultimately resulting in even greater dilation of the lumen.

The exchange of Na+ and H+ at the apical surface does not account for 100% of fluid reabsorption in the rat efferent ductules (19). Thus, other mechanisms, such as the Na+,K+-ATPase along the basolateral membrane (17), could be inhibited by the ICI 182,780 treatment. However, previous studies by our laboratory have shown that the general activity of Na+,K+-ATPase was dependent on circulating androgens and not estrogen (16). Furthermore, others have found that ICI treatment increases the expression of the Na+/K+,ATPase-{alpha}1 mRNA (51). Nevertheless, reabsorption of fluid in the efferent ductules is rapid (55) and essential for fertility (33); therefore, the existence of multiple mechanisms that could fine-tune this physiological process would be expected. The role that an overall balance of estrogen and androgens would play in this system remains to be determined.

The transient increase in lysosomal granules and height of microvilli in rat nonciliated cells of the efferent ductules were major differences from the {alpha}ERKO and ICI-treated mice. Microvilli and the endocytotic apparatus, including lysosomes, were reduced to insignificant levels in the {alpha}ERKO and ICI-treated mice (1, 6, 7, 8). In the rat, percent area of the lysosomes reached a peak between d 52 and d 73, but then there was a dramatic reduction by d 150. The cause of this difference in response between mice and rats is not known. The decrease in lysosomes in the rat corresponded to the induction of testicular atrophy; therefore, it is possible that the maintenance of lysosomes by the rat epithelium is dependent on active spermatogenesis and a corresponding luminal fluid milieu that is associated with the passage of sperm through the efferent ductules.

The rodent data clearly show that estrogen is important in the male reproductive tract. However, clear evidence of estrogen function in man has not been reported. An adult man with homozygous null mutation for ER{alpha} has been identified, but semen analysis was not reported (56). On the other hand, two aromatase-deficient men have been described both showing some effect on reproductive phenotype. Although direct extrapolation of data from the rodent to human is not possible, it is intriguing to consider that the youngest aromatase-deficient man (24 yr of age) had increased testis size (57), but the oldest (38 yr) showed reduced testicular size, severe azoospermia, and infertility (58, 59). These findings suggest that estrogens are also important for reproduction in man. The observations seen in the present study and in {alpha}ERKO males (1) recapitulate mechanisms that could account for an increase in testis size in the younger aromatase-deficient man, but decreased size in the older man having a deficiency in estrogen synthesis.

In conclusion, this study provides further evidence that estrogen is involved in the regulation of structure and function of the efferent ductules and that over time a functional ER is required for the expression of NHE3 as well as for maintenance of ion and fluid reabsorption, an essential function for long-term fertility in the rodent.


    Acknowledgments
 
We are grateful to the generous supply of ICI 182,780 provided by AstraZeneca, Macclesfield, UK, and to Dr. German A. B. Mahecha for valuable discussions.


    Footnotes
 
This work was supported by NIH Grant HD-35126 (to R.A.H.).

Abbreviations: 5{alpha}-DHT, 5{alpha}-Androstan-17ß-ol-3-one; {alpha}ERKO, knockout mouse ER-{alpha}; CAII, carbonic anhydrase; CFTR, cystic fibrosis transmembrane regulator; NHE3, Na+-H+ exchanger-3; PAS, periodic acid-Schiff.

Received October 16, 2001.

Accepted for publication February 26, 2002.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Hess RA, Bunick D, Lee KH, Bahr J, Taylor JA, Korach KS, Lubahn DB 1997 A role for oestrogens in the male reproductive system. Nature 390:509–512[CrossRef][Medline]
  2. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162–11166[Abstract/Free Full Text]
  3. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB, Korach KS 1996 Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137:4796–4805[Abstract]
  4. Couse JF, Korach KS 1998 Exploring the role of sex steroids through studies of receptor deficient mice. J Mol Med 76:497–511[CrossRef][Medline]
  5. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M 2000 Effect of single and compound knockouts of estrogen receptors {alpha} (ER {alpha}) and ß (ER ß) on mouse reproductive phenotypes. Development 127:4277–4291[Abstract]
  6. Nakai M, Bouma J, Nie R, Zhou Q, Carnes K, Lubahn DB, Hess RA 2001 Morphological analysis of endocytosis in efferent ductules of estrogen receptor-{alpha} knockout male mouse. Anat Rec 263:10–18[CrossRef][Medline]
  7. Lee KH, Hess RA, Bahr JM, Lubahn DB, Taylor J, Bunick D 2000 Estrogen receptor {alpha} has a functional role in the mouse rete testis and efferent ductules. Biol Reprod 63:1873–1880[Abstract/Free Full Text]
  8. Hess RA, Bunick D, Lubahn DB, Zhou Q, Bouma J 2000 Morphologic changes in efferent ductules and epididymis in estrogen receptor-{alpha} knockout mice. J Androl 21:107–121[Abstract]
  9. Hess RA, Gist DH, Bunick D, Lubahn DB, Farrell A, Bahr J, Cooke PS, Greene GL 1997 Estrogen receptor ({alpha} and ß) expression in the excurrent ducts of the adult male rat reproductive tract. J Androl 18:602–611[Abstract/Free Full Text]
  10. Fisher JS, Millar MR, Majdic G, Saunders PT, Fraser HM, Sharpe RM 1997 Immunolocalisation of oestrogen receptor-{alpha} within the testis and excurrent ducts of the rat and marmoset monkey from perinatal life to adulthood. J Endocrinol 153:485–495[Abstract/Free Full Text]
  11. Saunders PT, Sharpe RM, Williams K, Macpherson S, Urquart H, Irvine DS, Millar MR 2001 Differential expression of oestrogen receptor {alpha} and ß proteins in the testes and male reproductive system of human and non-human primates. Mol Hum Reprod 7:227–236[Abstract/Free Full Text]
  12. Goyal HO, Bartol FF, Wiley AA, Khalil MK, Chiu J, Vig MM 1997 Immunolocalization of androgen receptor and estrogen receptor in the developing testis and excurrent ducts of goats. Anat Rec 249:54–62[CrossRef][Medline]
  13. Mansour MM, Machen MR, Tarleton BJ, Wiley AA, Wower J, Bartol FF, Goyal HO 2001 Expression and molecular characterization of estrogen receptor {alpha} messenger RNA in male reproductive organs of adult goats. Biol Reprod 64:1432–1438[Abstract/Free Full Text]
  14. Nielsen M, Bogh IB, Schmidt M, Greve T 2001 Immunohistochemical localization of estrogen receptor-{alpha} in sex ducts and gonads of newborn piglets. Histochem Cell Biol 115:521–526[Medline]
  15. Clulow J, Jones RC, Hansen LA 1994 Micropuncture and cannulation studies of fluid composition and transport in the ductuli efferentes testis of the rat: comparisons with the homologous metanephric proximal tubule. Exp Physiol 79:915–928[Abstract]
  16. Ilio KY, Hess RA 1994 Structure and function of the ductuli efferentes: a review. Microsc Res Tech 29:432–467[CrossRef][Medline]
  17. Ilio KY, Hess RA 1992 Localization and activity of Na+,K+-ATPase in the ductuli efferentes of the rat. Anat Rec 234:190–200[CrossRef][Medline]
  18. Clulow J, Jones RC, Hansen LA, Man SY 1998 Fluid and electrolyte reabsorption in the ductuli efferentes testis. J Reprod Fertil Suppl 53:1–14
  19. Hansen LA, Clulow J, Jones RC 1999 The role of Na+-H+ exchange in fluid and solute transport in the rat efferent ducts. Exp Physiol 84:521–527[Abstract]
  20. Bagnis C, Marsolais M, Biemesderfer D, Laprade R, Breton S 2001 Na+/H+-exchange activity and immunolocalization of NHE3 in rat epididymis. Am J Physiol Renal Physiol 280:F426–F436
  21. Leung GPH, Tse CM, Cheng Chew SB, Wong PYD 2001 Expression of multiple Na+/H+ exchanger isoforms in cultured epithelial cells from rat efferent duct and cauda epididymidis. Biol Reprod 64:482–490[Abstract/Free Full Text]
  22. Fisher JS, Turner KJ, Fraser HM, Saunders PT, Brown D, Sharpe RM 1998 Immunoexpression of aquaporin-1 in the efferent ducts of the rat and marmoset monkey during development, its modulation by estrogens, and its possible role in fluid resorption. Endocrinology 139:3935–3945[Abstract/Free Full Text]
  23. Cohen JP, Hoffer AP, Rosen S 1976 Carbonic anhydrase localization in the epididymis and testis of the rat: histochemical and biochemical analysis. Biol Reprod 14:339–346[Abstract]
  24. Goyal HO, Ferguson JG, Hrudka F 1980 Histochemical activity of carbonic anhydrase in testicular and excurrent ducts of immature, mature intact and androgen-deprived bulls. Biol Reprod 22:991–997[Abstract]
  25. Zhou Q, Clarke L, Nie R, Carnes K, Lai LW, Lien YH, Verkman A, Lubahn D, Fisher JS, Katzenellenbogen BS, Hess RA 2001 Estrogen action and male fertility: roles of the sodium/hydrogen exchanger-3 and fluid reabsorption in reproductive tract function. Proc Natl Acad Sci USA 98:14132–14137[Abstract/Free Full Text]
  26. O’Donnell L, Robertson KM, Jones ME, Simpson ER 2001 Estrogen and spermatogenesis. Endocr Rev 22:289–318[Abstract/Free Full Text]
  27. Jordan VC, Robinson SP 1987 Species-specific pharmacology of antiestrogens: role of metabolism. Fed Proc 46:1870–1874[Medline]
  28. Gibson MK, Nemmers LA, Beckman Jr WC, Davis VL, Curtis SW, Korach KS 1991 The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129:2000–2010[Abstract/Free Full Text]
  29. Griffin MT, Pento JT, Magarian RA, Mousissian GK, Basmadjian GP 1990 Biodistribution of a novel antiestrogen (analog II) in the mouse and rat. Endocr Res 16:269–282[Medline]
  30. Matthews J, Celius T, Halgren R, Zacharewski T 2000 Differential estrogen receptor binding of estrogenic substances: a species comparison. J Steroid Biochem Mol Biol 74:223–234[CrossRef][Medline]
  31. Spearow JL, Doemeny P, Sera R, Leffler R, Barkley M 1999 Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 285:1259–1261[Abstract/Free Full Text]
  32. Hart JE 1990 Endocrine pathology of estrogens: species differences. Pharmacol Ther 47:203–218[CrossRef][Medline]
  33. Oliveira CA, Carnes K, França LR, Hess RA 2001 Infertility and testicular atrophy in the antiestrogen-treated adult male rat. Biol Reprod 65:913–920[Abstract/Free Full Text]
  34. Kuiper G, Shughrue PJ, Merchenthaler I, Gustafsson JA 1998 The estrogen receptor ß subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 19:253–286[CrossRef][Medline]
  35. Howell A, Osborne CK, Morris C, Wakeling AE 2000 ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 89:817–825[CrossRef][Medline]
  36. Wade GN, Blaustein JD, Gray JM, Meredith JM 1993 ICI 182,780: a pure antiestrogen that affects behaviors and energy balance in rats without acting in the brain. Am J Physiol 265:R1392–R1398
  37. NRC 1996 Guide for the care and use of laboratory animals. Washington, DC: National Academy Press
  38. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS 1999 Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 140:2976–2982[Abstract/Free Full Text]
  39. Jackson GL, Kuehl D, Rhim TJ 1991 Testosterone inhibits gonadotropin-releasing hormone pulse frequency in the male sheep. Biol Reprod 45:188–194[Abstract]
  40. Pujol A, Bayard F, Louvet JP, Boulard C 1976 Testosterone and dihydrotestosterone concentrations in plasma, epididymal tissues, and seminal fluid of adult rats. Endocrinology 98:111–113[Abstract/Free Full Text]
  41. Roselli CE, Resko JA 1984 Androgens regulate brain aromatase activity in adult male rats through a receptor mechanism. Endocrinology 114:2183–2189[Abstract/Free Full Text]
  42. Falvo RE, Nalbandov AV 1974 Radioimmunoassay of peripheral plasma testosterone in males from eight species using a specific antibody without chromatography. Endocrinology 95:1466–1468[Abstract/Free Full Text]
  43. Nakai M, Hashimoto Y, Kitagawa H, Kon Y, Sugimura M 1989 Effects of ligation of the ductus deferens on the fowl epididymal region. Nippon Juigaku Zasshi 51:521–529[Medline]
  44. Brewster ME, Anderson WR, Pop E 1997 Effect of sustained estradiol release in the intact male rat: correlation of estradiol serum levels with actions on body weight, serum testosterone, and peripheral androgen-dependent tissues. Physiol Behav 61:225–229[CrossRef][Medline]
  45. Lindzey J, Wetsel WC, Couse JF, Stoker T, Cooper R, Korach KS 1998 Effects of castration and chronic steroid treatments on hypothalamic gonadotropin-releasing hormone content and pituitary gonadotropins in male wild-type and estrogen receptor-{alpha} knockout mice. Endocrinology 139:4092–4101[Abstract/Free Full Text]
  46. Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley Jr WF 2000 Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 85:3027–3035[Abstract/Free Full Text]
  47. Hayes FJ, DeCruz S, Seminara SB, Boepple PA, Crowley Jr WF 2001 Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 86:53–58[Abstract/Free Full Text]
  48. Demay F, De Monti M, Tiffoche C, Vaillant C, Thieulant ML 2001 Steroid-independent activation of ER by GnRH in gonadotrope pituitary cells. Endocrinology 142:3340–3347[Abstract/Free Full Text]
  49. Robertson KM, O’Donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, Graves KH, McLachlan RI, Simpson ER 1999 Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci USA 96:7986–7991[Abstract/Free Full Text]
  50. Turner KJ, Morley M, Atanassova N, Swanston ID, Sharpe RM 2000 Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility. J Endocrinol 164:225–238[Abstract]
  51. Lee KH, Finnigan-Bunick C, Bahr J, Bunick D 2001 Estrogen regulation of ion transporter messenger RNA levels in mouse efferent ductules are mediated differentially through estrogen receptor (ER) {alpha} and ERß. Biol Reprod 65:1534–1541[Abstract/Free Full Text]
  52. Hess RA, Nakai M 2000 Histopathology of the male reproductive system induced by the fungicide benomyl. Histol Histopathol 15:207–224[Medline]
  53. Leung GP, Gong XD, Cheung KH, Cheng-Chew SB, Wong PY 2001 Expression of cystic fibrosis transmembrane conductance regulator in rat efferent duct epithelium. Biol Reprod 64:1509–1515[Abstract/Free Full Text]
  54. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors {alpha} and ß. Endocrinology 138:863–870[Abstract/Free Full Text]
  55. English HF 1979 Absorption in the ductuli efferentes testis of the rat. Anat Rec 193:531
  56. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056–1061[Abstract/Free Full Text]
  57. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689–3698[Abstract]
  58. Carani C, Qin K, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER 1997 Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91–95[Free Full Text]
  59. Rochira V, Faustini-Fustini M, Balestrieri A, Carani C 2000 Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J Clin Endocrinol Metab 85:1841–1845[Abstract/Free Full Text]
  60. Laborda J 1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998[Free Full Text]



This article has been cited by other articles:


Home page
J AndrolHome page
C. A. Oliveira, A. B. Victor-Costa, and R. A. Hess
Cellular and Regional Distributions of Ubiquitin-Proteasome and Endocytotic Pathway Components in the Epithelium of Rat Efferent Ductules and Initial Segment of the Epididymis
J Androl, September 1, 2009; 30(5): 590 - 601.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. Yasuhara, G. R. O. Gomes, E. R. Siu, C. I. Suenaga, E. Marostica, C. S. Porto, and M. F. M. Lazari
Effects of the Antiestrogen Fulvestrant (ICI 182,780) on Gene Expression of the Rat Efferent Ductules
Biol Reprod, September 1, 2008; 79(3): 432 - 441.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M L Gould, P R Hurst, and H D Nicholson
The effects of oestrogen receptors {alpha} and {beta} on testicular cell number and steroidogenesis in mice
Reproduction, August 1, 2007; 134(2): 271 - 279.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. J Meachem, S. Schlatt, S. M Ruwanpura, and P. G Stanton
The effect of testosterone, dihydrotestosterone and oestradiol on the re-initiation of spermatogenesis in the adult photoinhibited Djungarian hamster
J. Endocrinol., March 1, 2007; 192(3): 553 - 561.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
V. Stabile, M. Russo, and P. Chieffi
17{beta}-Estradiol induces Akt-1 through estrogen receptor-{beta} in the frog (Rana esculenta) male germ cells.
Reproduction, September 1, 2006; 132(3): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Da Silva, C. Silberstein, V. Beaulieu, C. Pietrement, A. N. Van Hoek, D. Brown, and S. Breton
Postnatal Expression of Aquaporins in Epithelial Cells of the Rat Epididymis
Biol Reprod, February 1, 2006; 74(2): 427 - 438.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. J Meachem, D. M Robertson, N. G Wreford, R. I McLachlan, and P. G Stanton
Oestrogen does not affect the restoration of spermatogenesis in the gonadotrophin-releasing hormone-immunised adult rat
J. Endocrinol., June 1, 2005; 185(3): 529 - 538.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
C. A Oliveira, G. A B Mahecha, K. Carnes, G. S Prins, P. T K Saunders, L. R Franca, and R. A Hess
Differential hormonal regulation of estrogen receptors ER{alpha} and ER{beta} and androgen receptor expression in rat efferent ductules
Reproduction, July 1, 2004; 128(1): 73 - 86.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Pais, I. Leav, K.-M. Lau, Z. Jiang, and S.-M. Ho
Estrogen Receptor-{beta} Expression in Human Testicular Germ Cell Tumors
Clin. Cancer Res., October 1, 2003; 9(12): 4475 - 4482.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
Q. Zhou, R. Nie, G. S. Prins, P. T. K. Saunders, B. S. Katzenellenbogen, and R. A. Hess
Localization of Androgen and Estrogen Receptors in Adult Male Mouse Reproductive Tract
J Androl, November 1, 2002; 23(6): 870 - 881.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliveira, C. A.
Right arrow Articles by Hess, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliveira, C. A.
Right arrow Articles by Hess, R. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals